Dry eye, also known as keratoconjunctivitis sicca, is a condition caused by inadequate tear production or unstable tear film. It results in ocular irritation, redness, and visual disturbance. The tear film consists of an outer lipid layer, middle aqueous layer, and inner mucin layer. In chronic dry eye, tears have increased salts and decreased proteins and lipocalins. Treatment focuses on lubricating the eyes, managing underlying conditions like blepharitis, and occasionally punctal plugs or anti-inflammatory drugs. Diagnosis involves tests of tear production, stability, and ocular surface staining to determine the best lubricating and anti-inflammatory treatments.
8. 12 Cranial nerves:
2nd Optic: vision (II)
3rd Oculomotor: eyelid and eyeball movement (III)
4th Trochlear: motor for vision (turns eye downward &
laterally) (IV)
5th Trigeminal: chewing, face and mouth touch and pain
6th Abducens: motor to lateral rectus muscles (VI)
7th Facial: controls most facial expressions , taste,
secretion of tears & saliva (VII)
9. Trigeminal 5th
The ophthalmic
nerve (V1) carries
sensory information
from the scalp and
forehead, the upper
eyelid, the conjunctiva
and cornea of the eye,
the nose, the nasal
mucosa, the frontal
sinuses, and parts of
the meninges.
13. 4. Conjunctival scarring with obstruction of lacrimal
gland ductules:
• Chemical burns
• Cicatrical pemphigoid
• Stevens- Johnson syndrome
• Old trachomas
5. Neurological lesions with sensory or motor reflex
loss:
• Familial dysautonomia
• Parkinson’s disease
• Reduced sensation after refractive surgery & CL wear
6. Vitamin A deficiency
16. Symptoms
• Feeling of dryness
• Grittiness & burning that worsen during the
day
• Stringy discharge
• Transient blurring of vision
• Redness & crusting of the lids
17. Signs
1. Posterior blepharitis & meibomian gland
dysfunction
2. Conjunctiva mild keratinaization & redness
3. Tear film:
• Particles & debris of accumlated lipid-
contaminated mucin.
• Thin/ absent tear meniscus
• Forth in tear film or along lid margin
//meibomian gland dysfunction.
24. Patient education:
• Realistic expectation of outcome.
• Emphasis on importance of compliance.
• Avoidance of toxic drugs or enviromental
factors .
• Discontinuation of toxic topical medication
if possible.
• Review of work enviroment.
• Emphasis on importance of blinking wilst
reading & using VDU.
• Aids should be provided for patients with
a loss of dexterity.
• Caution against laser refractive surgery.
• Discussion of management of CL
intolerance.
26. Tear substitutes:
2- Ointment:
Petrolatum mineral oil.
Used at bed time.
3- Mucolytic agents:
Useful in patients c corneal filaments &
mucus plaques
Acetylcysteine 5% drops q.i.d
It may cause irritation
Malodorous
Limited bottle life 2 wks max
28. Punctal occlusion:
To reduce drainage In moderate to severe cases
Temporary:
Inserting collagen plugs into the canaliculi that dissolve in 1-2
wks.
To ensure non-occurance of epiphoria following permanent
occlusion.
Occlusion of inferior puncta review after 2 wks No
symptoms permanent occlusion.
In severe KCS
plug of both inferior & superior canaliculi.
29. Punctal occlusion:
Reversible:
Prolonged occlusion (plugs that dissolve in 2–6 months.
Can cause extrusion, granuloma formation & distal migration.
Permanent:
Only in severe dry eye with schirmer test of 5mm or less.
Positive response to temporary plugs without epiphora.
Not in pt c reversible pathology.
Performed after punctal dilatation.
30. Lacrimal drainage.
Cannula inserted in lower
punctum after dilation.
Cannula is swung
towards the temporal
side before saline is
released.
On removing the cannula.
The punctum is now
wide and open.
31. Anti-inflammatory agents:
1- Low dose topical steroids:
Supplementary treatment for acute exacerbations.
Balance the risk of long-term ttt against benefit of
increased comfort.
2- Tropical ciclosporin:
↓ T-cell mediated lacrimal tissue inflammation
↑ no. of goblet cells.
3- Systemic tetracyclines:
Control associated blepharitis & reduce
inflammatory mediators in the tears.
32. Contact lenses:
Reservoir effect of fluid trapped behind the lens.
Low water (Hema) moderate cases.
Silicone (No water) to protect cornea in extreme cases
Occlusion gas permable scleral CL reservoire of saline
over the cornea (extremly dry).
33. Conservative of existing tears
1. Reduction of room temperature:
Avoiding central heating to minimize tear
evaporation.
2. Room humidifiers.
3. Moist chamber goggles.
4. Side shields to glasses.
34. Other options
1. Tarsorrhapy reducing palbebral aperture.
2. Botulinum toxin injection control
blepharospasm.
3. Oral chlinergic agonists Pilocarbine (5mg
q.i.d), Sjogren.
4. Zidovudine antiretroviral agent, Sjogren.
5. Submandibular gland transplantation
extreme dry, requires surgery, produce
unacceptable level of mucus in the tear film.
35.
36. Dry eye medication in
the Saudi market:
Cellulose derivatives:
Carboxymethylcellulose Sodium 0.5%
Aqueous insufficiency & lubricant.